Science

First newly developed ELISA of risk class B declared IVDR-compliant

Anti-TBE Virus ELISA 2.0 (IgG) After EUROIMMUN received the required certificate for its quality management system in accordance with the new European Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May of this year, the first newly developed IVD product of risk class B has now also been declared IVDR-compliant and launched […]

Science

Omicron-induced T- and B-cell immunity in vaccinated and naïve individuals

A recent study has demonstrated substantial differences in SARS-CoV-2 immunity after Omicron infection in triple-COVID-19-vaccinated and antigen-naïve individuals, which may influence cross-protection against future variants. The study was performed as part of a collaboration between the Hannover Medical School, Germany and EUROIMMUN. Omicron variants are B-cell immune escape variants of SARS-CoV-2 that elude the defence

Science

Schleswig-Holstein’s Minister of Economic Affairs visits EUROIMMUN

Claus Ruhe Madsen, Minister of Economic Affairs, Transport, Employment, Technology and Tourism of the German state of Schleswig-Holstein, together with Dr. Jürgen Walkenhorst and Dr. Georg Eschenburg of the association “Life Science Nord”, visited EUROIMMUN’s headquarters in Lübeck last week to gain an insight into the work of the laboratory diagnostic products manufacturer and its

Science

A life-saving diagnosis thanks to comprehensive antibody testing – a motivating success story

In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease that mainly affects the connective tissue and muscles. Today he is treated with immunosuppressants and is doing well, but receiving this diagnosis and successful therapy

Scroll to Top